hengrui glp-1 China Medicine has registered a Phase III, multicenter, randomized, double-blind clinical trial of the GLP-1R/GIPR dual agonist HRS9531 for the treatment of obesity (NCT06396429; HRS9531-301) Hengrui Pharma and Kailera Therapeutics

hengrui glp-1

hengrui glp-1 China Medicine has registered a Phase III, multicenter, randomized, double-blind clinical trial of the GLP-1R/GIPR dual agonist HRS9531 for the treatment of obesity (NCT06396429; HRS9531-301) Hengrui Pharma and Kailera Therapeutics

Name: hengrui glp-1 China Medicine has registered a Phase III, multicenter, randomized, double-blind clinical trial of the GLP-1R/GIPR dual agonist HRS9531 for the treatment of obesity (NCT06396429; HRS9531-301) Hengrui Pharma and Kailera Therapeutics
Brand: neboallen.info
SKU: 75352340566
Price: 20.56 USD
Availability: InStock
Rating: 4.0279 (8 reviews)

SKU: 75352340566

4.0

EUR20.56 EUR41.56

Pay in 4 interest-free payments of $5.14 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 19 - Aug 24

Description

Technology Technology Drive whats next in tech while working with cutting-edge AI tools to enhance productivity, accelerate development and continuously improve code quality across platforms like iOS, Android, AWS, Java, machine learning and more